Prostanoid receptors: Subtypes and signaling

被引:792
作者
Breyer, RM
Bagdassarian, CK
Myers, SA
Breyer, MD
机构
[1] Vanderbilt Univ, Div Nephrol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[4] Coll William & Mary, Dept Chem, Williamsburg, VA 23187 USA
[5] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[6] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA
关键词
prostaglandin; GPCR; G protein; mutagenesis; alternative splicing;
D O I
10.1146/annurev.pharmtox.41.1.661
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE(2), PGF(2 alpha), PGI(2), TxA(2), and PGD(2). These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP1, EP3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.
引用
收藏
页码:661 / 690
页数:30
相关论文
共 156 条
[1]   RAT KIDNEY THROMBOXANE RECEPTOR - MOLECULAR-CLONING, SIGNAL-TRANSDUCTION, AND INTRARENAL EXPRESSION LOCALIZATION [J].
ABE, T ;
TAKEUCHI, K ;
TAKAHASHI, N ;
TSUTSUMI, E ;
TANIYAMA, Y ;
ABE, K .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :657-664
[2]   The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs [J].
Abramovitz, M ;
Adam, M ;
Boie, Y ;
Carrière, MC ;
Denis, D ;
Godbout, C ;
Lamontagne, S ;
Rochette, C ;
Sawyer, N ;
Tremblay, NM ;
Belley, M ;
Gallant, M ;
Dufresne, C ;
Gareau, Y ;
Ruel, R ;
Juteau, H ;
Labelle, M ;
Ouimet, N ;
Metters, KM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1483 (02) :285-293
[3]  
ABRAMOVITZ M, 1995, ADV PROSTAG THROMB L, V23, P499
[4]  
ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632
[5]   CLONING AND EXPRESSION OF 3 ISOFORMS OF THE HUMAN EP(3) PROSTANOID RECEPTOR [J].
ADAM, M ;
BOIE, Y ;
RUSHMORE, TH ;
MULLER, G ;
BASTIEN, L ;
MCKEE, KT ;
METTERS, KM ;
ABRAMOVITZ, M .
FEBS LETTERS, 1994, 338 (02) :170-174
[6]   ISOFORMS OF THE EP3 SUBTYPE OF HUMAN PROSTAGLANDIN E(2) RECEPTOR TRANSDUCE BOTH INTRACELLULAR CALCIUM AND CAMP SIGNALS [J].
AN, SZ ;
YANG, JH ;
SO, SW ;
ZENG, L ;
GOETZL, EJ .
BIOCHEMISTRY, 1994, 33 (48) :14496-14502
[7]   CLONING AND EXPRESSION OF THE EP2 SUBTYPE OF HUMAN RECEPTORS FOR PROSTAGLANDIN-E2 [J].
AN, SZ ;
YANG, JH ;
XIA, MH ;
GOETZL, EJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (01) :263-270
[8]   Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases [J].
Aoki, J ;
Katoh, H ;
Yasui, H ;
Yamaguchi, Y ;
Nakamura, K ;
Hasegawa, H ;
Ichikawa, A ;
Negishi, M .
BIOCHEMICAL JOURNAL, 1999, 340 :365-369
[9]   Prostaglandin E(2) activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: Involvement of EP1 and EP3 receptor subtypes [J].
Asboth, G ;
Phaneuf, S ;
EuropeFinner, GN ;
Toth, M ;
Bernal, AL .
ENDOCRINOLOGY, 1996, 137 (06) :2572-2579
[10]   Substitution of charged amino acid residues in transmembrane regions 6 and 7 affect ligand binding and signal transduction of the prostaglandin EP(3) receptor [J].
Audoly, L ;
Breyer, RM .
MOLECULAR PHARMACOLOGY, 1997, 51 (01) :61-68